Agendia Announces Five Studies in Breast Cancer for Presentation at the American Society of Clinical Oncology 2012 Breast Cancer Symposium
AMSTERDAM, THE NETHERLANDS, and IRVINE, CA, September 13, 2012 – Agendia, an Read More
Agendia Brings Together Thought Leaders in Molecular Diagnostics and Medical Oncology
IRVINE, CA and AMSTERDAM, THE NETHERLANDS, August 29, 2012 – Read More
Agendia Earns ISO Certification for Facilities in Amsterdam and Irvine
IRVINE, CA and AMSTERDAM, THE NETHERLANDS, August 20, 2012 – Read More
Agendia Appoints Dr. Stefan Glück to Chair Medical Advisory Board
IRVINE, CA and AMSTERDAM, THE NETHERLANDS, August 9, 2012 – Read More
Agendia Welcomes Dr. Mark Gittleman to Expanding Medical Advisory Board
IRVINE, CA and AMSTERDAM, THE NETHERLANDS, July 10, 2012 – Read More
Agendia Names Industry Veteran Glen Fredenberg CFO and Vice President of Finance
IRVINE, CA and AMSTERDAM, THE NETHERLANDS, July 9, 2012 – Read More
Agendia Announces Launch of ColoPrint for Colon Cancer Prognosis and Prediction
Agendia’s Microarray-based Gene Expression Profile Provides Critical Additional Information for Read More
Agendia Raises $65 Million in a Private Round of Equity Financing
IRVINE, CA and AMSTERDAM, THE NETHERLANDS, May 31, 2012 – Read More
Agendia Announces Nine Studies in Breast and Colon Cancer for Presentation at 2012 Annual Meeting of the American Society of Clinical Oncology (ASCO)
AMSTERDAM, THE NETHERLANDS, and IRVINE, CA, May 29, 2012 – Read More
RASTER: First-Ever Prospective Diagnostic Study in Breast Cancer
RASTER Five-Year Follow-Up Data Indicates Chemotherapy May Be Safely Withheld Read More
